A carregar...

Inhibition of p53 and/or AKT as a new therapeutic approach specifically targeting ALT cancers

Abstract While the majority of all human cancers counteract telomere shortening by expressing telomerase, ~15% of all cancers maintain telomere length by a telomerase-independent mechanism known as alternative lengthening of telomeres (ALT). Here, we show that high load of intrinsic DNA damage is pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Yuanlong Ge, Shu Wu, Zepeng Zhang, Xiaocui Li, Feng Li, Siyu Yan, Haiying Liu, Junjiu Huang, Yong Zhao
Formato: Artigo
Idioma:Inglês
Publicado em: SpringerOpen 2019-05-01
Colecção:Protein & Cell
Assuntos:
ALT
p53
AKT
Acesso em linha:http://link.springer.com/article/10.1007/s13238-019-0634-z
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!